Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000692024 | SCV000819831 | likely pathogenic | Isovaleryl-CoA dehydrogenase deficiency | 2019-10-22 | criteria provided, single submitter | clinical testing | This sequence change results in a premature translational stop signal in the IVD gene (p.Arg398*). While this is not anticipated to result in nonsense mediated decay, it is expected to delete the last 29 amino acids of the IVD protein. This variant is present in population databases (rs398123681, ExAC 0.02%). This variant has not been reported in the literature in individuals with IVD-related disease. ClinVar contains an entry for this variant (Variation ID: 571005). Two missense substitutions (p.Arg398Gln, p.Ile405Thr) that lie at this codon or downstream of it have been determined to be likely pathogenic (PMID: 22960500, 24516753, Invitae). This suggests that deletion of this region of the IVD protein is causative of disease. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Baylor Genetics | RCV000692024 | SCV001163391 | pathogenic | Isovaleryl-CoA dehydrogenase deficiency | criteria provided, single submitter | clinical testing | ||
Knight Diagnostic Laboratories, |
RCV000692024 | SCV001448849 | likely pathogenic | Isovaleryl-CoA dehydrogenase deficiency | 2018-12-17 | criteria provided, single submitter | clinical testing |